Skip to content

Effects of Citicoline in patients with traumatic concussion

effects of citicoline on the healing process of patients with traumatic concussion

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140611018063N7
Enrollment
30
Registered
2020-03-21
Start date
2016-05-21
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head trauma. Diffuse brain injury

Interventions

Intervention 1: Intervention group 1: In this groups, the patients will be treated with received intravenous (IV) citicoline with a dosage of 0.5 gr/ twice a day(group B) and the treatment period will

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 60 Years

Inclusion criteria

Inclusion criteria: Traumatic Head concussion GCS lower or equal to 8 Hospitalized in ICU and Neurosurgery ward Age between 5 to 60 years

Exclusion criteria

Exclusion criteria: severe cognitive disorders severe systemic disorder penetrating or open skull trauma severe chest or lung trauma subdural or large epidoral hematoma requiring surgery younger than 5 or older than 60 years pregnant women

Design outcomes

Primary

MeasureTime frame
Level of consciousness in a patients. Timepoint: First 7 days and on 14th day of hospitalization. Method of measurement: Glasgow Coma Scale scoring system.;Muscle strength degree. Timepoint: The first week, on day 14, 21 and 30 of hospitalization. Method of measurement: Manual Muscle Testing scale.;Contusion volume and cerebral edema. Timepoint: Days 1, 3, 5 and 7. Method of measurement: Computed Tomography scans.;Length of dependency on a ventilator. Timepoint: 30 days of hospitalization. Method of measurement: Documentary Registry Data.;Stay length in the intensive care unit. Timepoint: 30 days of hospitalization. Method of measurement: Documentary Registry Data.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoroush Hozeifi

Birjand University of Medical Sciences

soroush.hozeifi@gmail.com+98 56 3239 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026